Advertisement
AD

Main navigation

Major Bitcoin Rival, Gold, Drops, While BTC Breaks Above $41,000

Advertisement
Fri, 6/08/2021 - 13:53
Major Bitcoin Rival, Gold, Drops, While BTC Breaks Above $41,000
Cover image via stock.adobe.com
Read U.TODAY on
Google News

Spot gold (XAU) has seen a fall of over 1.5 percent, trading at $1,772 per ounce at press time. This is a continuation of the fall that began on Wednesday when gold was changing hands at $1,828.

Advertisement

Since then, the traditional store of value has lost 3.08 percent of its value.

9028_0
Image via TradingView

Its rival in the world of digital finance, flagship cryptocurrency Bitcoin, remains on the rise and is trading above the $41,000 level at the moment, according to figures provided by CoinMarketCap.

Three days ago, Bitcoin influencer Anthony Pompliano shared that in the past 12 months, gold has lost 10 percent of its value, while the digital store of value, BTC, rose by a whopping 249 percent.

Trader and analyst Willy Woo commented that gold and Bitcoin are "inversely correlated" and BTC has been absorbing capital from other major global assets, including gold.

Since August 2020, gold has been unable to recover above its peak price above $2,000.

Some are betting both on gold and Bitcoin, though. One of these investors is Robert Kiyosaki, prominent entrepreneur, investor and author of the best selling book on financial self-education, "Rich Dad, Poor Dad."

Related
John Lennon’s Son Supports Cardano Creator in His Criticism of Crypto Taxation Amendment

Since last year, he has been investing heavily in both gold and Bitcoin (and silver as well), expecting non-transitory inflation and a devaluation of the U.S. dollar due to the growing monetary stimuli being implemented by the U.S. government, both under the former and current presidential administrations.

Advertisement
TopCryptoNewsinYourMailbox
TopCryptoNewsinYourMailbox
Advertisement

Latest Press Releases

Our social media
There's a lot to see there, too

Popular articles

Advertisement
AD